Medical Advisory Board

Diadem is working with a top level international Advisory Board who strongly believes in the technology
Jeffrey Cummings

Jeffrey Cummings

MD, ScD.
Professor of Neurology of the Cleveland Clinic Lerner College of Medicine, Research Professor of the University of Nevada Las Vegas and formerly Professor and researcher at UCLA
Robert Dean

Robert Dean

Ph.D. MD.
Served as a clinical research pathologist at Eli Lilly & Company from 1995-2017, focusing on biomarker discovery and development with application to translational research and diagnostics development
Giovanni Frisoni

Giovanni Frisoni

Ph.D. MD.
Professor of Clinical Neuroscience, Head of Memory Clinic, University Hospital of Geneva and University of Geneva. Editor of Neurobiology of Aging in Imaging and an editorial board member for The Lancet Neurology. Principal investigator in important research studies on neuroimaging and the understanding of Alzheimer’s disease
Anne Fagan

Anne Fagan

Ph.D.
Professor of Neurology at Washington University School of Medicine and the Fluid Biomarker Core Leader of several large studies of biomarkers in Alzheimer’s disease